Crossmark

Platelet-rich plasma treatment for large joint osteoarthritis: retrospective study highlighting a possible treatment protocol with long-lasting stimulation of the joint with an adequate dose of platelets

Crossref DOI link: https://doi.org/10.1186/s12891-025-08663-3

Published Online: 2025-04-24

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Schwitzguébel, Adrien

Corzo, Alfredo Hernandez

Theodoridou, Efstathia

Bogoev, Mitko

Grange, Matthieu

Boudabbous, Sana

Benaim, Charles
License Information

Text and Data Mining valid from 2025-04-24

Version of Record valid from 2025-04-24
More Information

Article History

Received: 13 March 2024

Accepted: 15 April 2025

First Online: 24 April 2025

Declarations

:

: The study was conducted in accordance with the Declaration of Helsinki, and approved by the Institutional Ethics Committee of the Canton of Vaud (CER-VD), affiliated with Lausanne University Hospital (CHUV), Switzerland (AO2020-00006; 24.11.2020).

: Not applicable.

: Written informed consent has been obtained from the patient(s) to publish this paper. Informed consent for participation was obtained from all the patients.

Document is current

Any future updates will be listed below